- Home
- ICU vs ABP Comparison
ICU vs ABP Comparison
Compare ICU & ABP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICU
- ABP
- Stock Information
- Founded
- ICU 2018
- ABP 2004
- Country
- ICU United States
- ABP United States
- Employees
- ICU N/A
- ABP N/A
- Industry
- ICU Biotechnology: Pharmaceutical Preparations
- ABP Biotechnology: Pharmaceutical Preparations
- Sector
- ICU Health Care
- ABP Health Care
- Exchange
- ICU Nasdaq
- ABP Nasdaq
- Market Cap
- ICU 15.9M
- ABP 18.8M
- IPO Year
- ICU N/A
- ABP N/A
- Fundamental
- Price
- ICU $0.31
- ABP $6.76
- Analyst Decision
- ICU
- ABP Hold
- Analyst Count
- ICU 0
- ABP 1
- Target Price
- ICU N/A
- ABP N/A
- AVG Volume (30 Days)
- ICU 919.2K
- ABP 209.8K
- Earning Date
- ICU 11-13-2025
- ABP 11-14-2025
- Dividend Yield
- ICU N/A
- ABP N/A
- EPS Growth
- ICU N/A
- ABP N/A
- EPS
- ICU N/A
- ABP N/A
- Revenue
- ICU $881,000.00
- ABP N/A
- Revenue This Year
- ICU $820.00
- ABP N/A
- Revenue Next Year
- ICU $63.37
- ABP N/A
- P/E Ratio
- ICU N/A
- ABP N/A
- Revenue Growth
- ICU 1195.59
- ABP 50.00
- 52 Week Low
- ICU $0.29
- ABP $4.55
- 52 Week High
- ICU $3.07
- ABP $153.90
- Technical
- Relative Strength Index (RSI)
- ICU 27.08
- ABP 89.20
- Support Level
- ICU $0.30
- ABP $5.34
- Resistance Level
- ICU $0.52
- ABP $6.14
- Average True Range (ATR)
- ICU 0.05
- ABP 0.49
- MACD
- ICU -0.01
- ABP 0.04
- Stochastic Oscillator
- ICU 6.96
- ABP 75.89
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
About ABP Abpro Holdings Inc Common Stock
Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.